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Liver MR relaxometry at 3T – 
segmental normal t1 and t2* values 
in patients without focal or diffuse 
liver disease and in patients with 
increased liver fat and elevated liver 
stiffness
V. C. obmann  1, N. Mertineit1, C. Marx1, A. Berzigotti2, L. ebner1, J. t. Heverhagen1, 
A. Christe1 & A. t. Huber1
Magnetic resonance (MR) t1 and t2* mapping allows quantification of liver relaxation times for non-
invasive characterization of diffuse liver disease. We hypothesized that liver relaxation times are not 
only influenced by liver fibrosis, inflammation and fat, but also by air in liver segments adjacent to 
the lung – especially in MR imaging at 3T. A total of 161 study participants were recruited, while 6 
patients had to be excluded due to claustrophobia or technically uninterpretable MR elastography. 
Resulting study population consisted of 12 healthy volunteers and 143 patients who prospectively 
underwent multiparametric MR imaging at 3T. Of those 143 patients, 79 had normal liver stiffness 
in MR elastography (shear modulus <2.8 kPa, indicating absence of fibrosis) and normal proton 
density fat fraction (pDFF < 10%, indicating absence of steatosis), defined as reference population. T1 
relaxation times in these patients were significantly shorter in liver segments adjacent to the lung than 
in those not adjacent to the lung (p < 0.001, mean of differences 33 ms). In liver segments not adjacent 
to the lung, t1 allowed to differentiate significantly between the reference population and patients 
with steatosis and/or fibrosis (p ≤ 0.011), while there was no significant difference of T1 between the 
reference population and healthy volunteers. In conclusion, we propose to measure T1 relaxation times 
in liver segments not adjacent to the lung. Otherwise, we recommend taking into account slightly 
shorter t1 values in liver segments adjacent to the lung.
Magnetic resonance (MR) imaging of the liver is a powerful tool in diagnosis of focal liver disease and is fre-
quently used in clinical routine1,2. Most conventional liver MR sequences measure relative signal intensities and 
therefore allow relative comparison between focal disease and adjacent normal hepatic parenchyma3. However, 
detection and quantification of diffuse liver disease remains challenging4 but is desirable to avoid invasive and 
expensive biopsies5.
Currently, existing non-invasive imaging biomarkers for diffuse liver disease include proton density fat 
fraction (PDFF) calculation6 and MR elastography7,8. Another emerging technique is the quantification of T1 
relaxation time on parametric maps, which is routinely used in cardiac imaging9, for example in diffuse cardiac 
fibrosis10,11 or myocarditis12. Recently, the modified Look-Locker inversion recovery sequence (MOLLI) demon-
strated great potential for application in diffuse liver disease13,14.
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However, as known from cardiac applications, reference values should be established for different manufactur-
ers, technical parameters and field strengths before using T1 mapping in clinical routine15,16. Further, it is known 
from cardiac imaging that T1 values might be influenced if measured in the ventricle close to the lung, why usually 
measurements in the septum are preferred17. Therefore, specific anatomical conditions of the liver with adjacent 
air-containing lungs and potential internal confounders, such as hepatic fat and iron composition, should be 
considered in hepatic T1 mapping2.
We hypothesized that T1 relaxation time is significantly shorter in liver segments adjacent to the lung than in 
liver segments not adjacent to the lung due to air-induced susceptibility effects at 3T.
Results
patient characteristics. Patient characteristics are shown in Table 1. Patients without steatosis but with 
increased liver stiffness (shear modulus ≥ 2.8 kPa) showed a male predominance (78% males vs. 43% males in 
patients without fibrosis), a higher prevalence of diabetes (35% vs. 3%, p < 0.001), elevated GGT (110 ± 143 vs. 
30 ± 33, p < 0.001), and prolonged extrinsic coagulation times (Quick 81 ± 20% vs. 99 ± 3%, p < 0.001). There 
was a tendency for more tobacco smokers in the group with increased liver stiffness, without statistical signifi-
cance (p = 0.091). None of the patients was taking empagliflozin and only one patient was taking ezetimibe, both 
known to reduce liver fat as measured with PDFF18,19.
Image quality. Out of 143 patients and 12 volunteers, resulting in 155 participants, there was at least one 
segment of good diagnostic image quality in 152/155 participants (98%) for T1 and in 149/155 participants (96%) 
for T2* (Table 2). In the right liver, segments V-VIII were measurable in at least 90% of the patients for T1. For 
T2*, the left liver segments were just measurable in 21–40%, while on the right side, the cranial right segments 
(VII and VIII) were measurable in 61–63% of patients and the right caudal segments (V and VI) were measurable 
in 86–88% of patients.
Location-based mapping results. As shown in Table 3 and demonstrated in Fig. 1, T1 values were sig-
nificantly lower in the cranial slices than in the caudal slices (mean of the differences 33 ms, p < 0.001). This did 
Reference 
population (n = 79)  
No steatosis 
(PDFF < 10%) 
Normal liver 
stiffness (shear 
modulus ≤ 2.8 kPa)
Positive Controls 1(n = 23)
No steatosis 
(PDFF < 10%) Increased 
liver stiffness (shear 
modulus ≥ 2.8 kPa) p - value
Positive Controls 2 (n = 26)  
Steatosis (PDFF > 10%) 
Normal liver stiffness 
(shear modulus ≤ 2.8 kPa)
Positive Controls 3 (n = 15) 
Steatosis (PDFF > 10%) 
Increased liver stiffness 
(shear modulus ≥ 2.8 kPa) p - value
Negative 
Controls 
(n = 12)  
Healthy 
Volunteers
Age, years 51 ± 14 59 ± 13 0.023 56 ± 11 57 ± 12 0.925 31 ± 9
Male, % 34 (43%) 18 (78%) 0.004 15 (58%) 13 (87%) 0.084 7 (58%)
BMI, kg/m2 26 ± 8 27 ± 6 0.039 29 ± 5** 31 ± 7 0.559 22 ± 2
Tobacco 14 (18%) 8 (35%) 0.091 2 (8%) 7 (47%) 0.006 0 (0%)
Arterial hypertension 14 (18%) 7 (30%) 0.241 7 (27%) 5 (33%) 0.730 0 (0%)
Dyslipidaemia 8 (10%) 5 (22%) 0.162 0 (0%) 3 (20%) 0.043 0 (0%)
Diabetes Type 2 2 (3%) 8 (35%) <0.001 3 (12%) 2 (13%) >0.999 0 (0%)
Chronic renal insufficiency 1 (1%) 1 (4%) 0.402 0 (0%) 0 (0%) >0.999 0 (0%)
≥1 medicament daily 20 (25%) 12 (52%) 0.021 6 (23%) 6 (40%) 0.300 0 (20%)
≥2 medicaments daily 5 (6%) 8 (35%) 0.001 2 (8%) 4 (27%) 0.168 0 (0%)
ASAT, U/l 24 ± 9 39 ± 23 0.029 29 ± 22 47 ± 30 0.041 N/A
ALAT, U/l 30 ± 41 36 ± 27 0.003 34 ± 21 55 ± 36 0.092 N/A
GGT, U/l 30 ± 33 110 ± 143  <0.001 37 ± 22 75 ± 67 0.224 N/A
Alkaline phosphatase, U/l 73 ± 36 87 ± 46 0.107 78 ± 19 88 ± 57 0.745 N/A
Bilirubin, μmol/l 10 ± 7 19 ± 17 0.016 8 ± 3 18 ± 15 0.281 N/A
Albumin 37 ± 3 35 ± 4 0.304 29 ± 15 34 ± 5 0.902 N/A
Quick, % 99 ± 3 81 ± 20 <0.001 95 ± 8 85 ± 23 0.601 N/A
APRI 0.73 ± 1.61 1.12 ± 1.00 0.039 0.67 ± 0.74 0.87 ± 1.15 >0.999 N/A
Creatinine, μmol/l 78 ± 22 76 ± 17 0.792 84 ± 21 82 ± 19 0.799 N/A
Combined: Diabetes, 
Dyslipidaemia, BMI > 25 1 (1%) 2 (9%) 0.127 0 (0%) 2 (13%) 0.128 N/A
Combined: Smoking, 
Diabetes, Dyslipidaemia, 
BMI > 25
1 (1%) 1 (4%) 0.402 0 (0%) 2 (13%) 0.128 N/A
Table 1. Patient characteristics of the MR elastography study population (patients n = 143, volunteers n = 12, total 
n = 155). Values represent the mean ± SD or n. P-values were calculated using the Mann-Whitney U or Fisher’s 
exact test, as appropriate. Comparisons between the two patient groups with steatosis and the reference group 
in the first column are indicated with *p < 0.05; **p < 0.001. MR = magnetic resonance; PDFF = proton density 
fat fraction; BMI = body mass index; ASAT = aspartate aminotransferase; ALAT = alanine aminotransferase; 
GGT = gamma-glutamyltransferase; APRI = aspartate aminotransferase-to-platelet ratio index.
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not count for the comparison between cranial segment II and caudal segment III, where no significant difference 
between both segments was detected (6 ms, p = 0.365). Values between segments were very comparable on each 
level, except for segment II, which showed values more comparable with the caudal level segments (Table 3). The 
same tendencies, but less pronounced, were observed for T2*.
Normal T1 values in reference patients were as follows: T1 = 780 ± 83 ms (segments not adjacent to the lung) 
and 746 ± 81 ms (segments adjacent to the lung) (Table 4). There were no significant differences between the 
younger healthy volunteers and the reference population (p = 0.358 for T1 and p = 0.521 for T2*).
In positive patients with steatosis as well as in patients with increased liver stiffness, T1 relaxation time was 
significantly longer than in the reference population (p = 0.019 and p = 0.011 and p < 0.001 for steatosis only, 
increased stiffness ≥ 2.8 kPa only and increased stiffness ≥ 3.5 kPa only, respectively). These results are illustrated 
in Fig. 2.
Multivariate analysis. In multivariate analysis of patients and volunteers without focal or diffuse liver dis-
ease, T2* time was a significant confounder of T1 time (p < 10−15), while PDFF, age and sex (p = 0.249, 0.722, 
0.687, respectively) were not (Fig. 3).
Inter-reader reliability. The ICC values were excellent for both T1 and T2*, as measured in segment VI. The 
ICC was 0.97 (95%-CI: 0.91–0.99) for T1 and 0.91 (95%-CI: 0.78–0.97) for T2*.
Discussion
This study shows that T1 relaxation time is significantly shorter in liver segments adjacent to the lung than in 
liver segments not adjacent to the lung. We calculated a mean T1 value of 780 ± 83 ms at 3T in liver segments not 
adjacent to the lung (segments II, III, IVb, V, VI), while T1 was around 30 ms shorter in liver segments adjacent to 
the lung (segments IVa, VII, VIII) in a patient population, without focal (based on CT) or diffuse (based on PDFF 
and MR elastography) liver disease.
Participants with good 
image quality
Segment VI/
VII p-value
Segment V/
VIII p-value
Segment 
IVa/b p-value
Segment 
II/III p-value
T1 152/155 (98%)
Upper level VII/VIII/IVa/II 140 (90%) 0.006 143 (92%) 0.031 135 (87%) <0.001 134 (86%) <0.001
Lower level VI/V/IVb/III 140 (90%) 0.006 147 (95%) 0.218 102 (66%) <0.001 88 (57%) <0.001
T2* 149/155 (96%)
Upper level VII/VIII/IVa/II 95 (61%) <0.001 97 (63%) <0.001 62 (40%) <0.001 58 (37%) <0.001
Lower level VI/V/IVb/III 137 (88%) 0.018 134 (86%) 0.004 58 (37%) <0.001 33 (21%) <0.001
Table 2. Mapping quality in different liver segments in all study participants (patients n = 143, volunteers 
n = 12, total n = 155). Values represent the numbers of participant with liver segments with good image quality 
on T1 and T2* maps, respectively. Relative portion compared to total study population (n = 155) is shown with 
the % shown in brackets. The first column indicates the number of participants with at least one segment with 
good image quality, followed by the number of participants with good image quality maps in Segment VI/VII, 
V/VIII, Iva/B and II/III, respectively. In the upper part of the Table results for T1, in the lower part results for 
T2* are described. P-values were calculated using Fisher’s exact test to compare the number of segments with 
good image quality at every localization to the number of at least one segment with good quality per patient.
All liver 
segments N
Segment VI/
VII N
Segment V/
VIII N
Segment 
IVa/b N Segment II/III N
T1 All segments 767 ± 82 ms 78
Upper level VII/VIII/IVa/II 751 ± 82 ms 78 742 ± 82 ms* 72 744 ± 84 ms* 76 752 ± 86 ms 72 770 ± 87 ms** 67
Lower level VI/V/IVb/III 781 ± 84 ms 77 776 ± 85 ms* 73 785 ± 89 ms 76 775 ± 110 ms 61 776 ± 83 ms 43
Mean of the 
differences 33 ms 34 ms 42 ms 27 ms 6 ms
P-value <0.001 <0.001 <0.001 <0.001 0.365
T2* All segments 20 ± 5 ms 76
Upper level VII/VIII/IVa/II 19 ± 6 ms 60 18 ± 6 ms 50 18 ± 5 ms* 49 18 ± 6 ms 33 21 ± 7 ms** 32
Lower level VI/V/IVb/III 20 ± 5 ms 75 20 ± 5 ms 68 20 ± 5 ms 67 20 ± 6 ms 30 19 ± 6 ms 15
Mean of the 
differences 0.9 ms 1.7 ms 1.6 ms 0.6 ms −0.9 ms
P-value 0.013 <0.001 <0.001 0.567 0.082
Table 3. Reference values in different liver segments in patients with normal liver stiffness without steatosis 
(n = 79). Values represent the mean ± SD or n. P-values were calculated using a paired Mann-Whitney U test 
to compare upper and lower levels and each liver segment with the mean value of all liver segments of the same 
level: *p < 0.05; **p < 0.001.
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This difference may be explained by different reasons. One possibility are susceptibility effects from adja-
cent air in the lungs. Susceptibility differences between liver and lungs cause off-resonance, which may lead 
to T1 underestimation. Similar effects are known from myocardial T1 mapping20,21. In addition, there is a 
T2-dependency of the MOLLI based T1 mapping sequence due to its bSSFP design, therefore influencing the 
measured T1 value. Another explanation might be partial volume effects at the liver dome since the slice thick-
ness is 10 mm (Fig. 4), which is also known from neuroimaging22. However, the regions of interests (ROI) were 
drawn carefully to exclude liver vessels and outer 10 mm of the liver border, to prevent this possible bias as much 
as possible.
While differences between cranial and caudal segments in the right liver lobe and segment IVa vs. IVb were 
comparable, the T1 relaxation time difference between segment II and III was smaller. A potential explanation 
for this different behaviour might be that segment II is in close anatomical neighborhood to the heart and not to 
the lungs as the cranial segments VII, VIII and IVb are. We therefore propose to measure T1 relaxation time in 
liver segments V and VI with excellent inter-reader-reliability, when a representative T1 quantification of the liver 
is intended. These segments are normally targeted for liver biopsy and may be regarded as representative for the 
whole liver. However, for a more detailed segmental analysis of T1 relaxation times in the liver shorter normal 
T1 values in liver segments adjacent to the lung should be taken into account. T2* seems to be more prone to 
respiratory and pulsation artefacts from the beating heart, which might explain lower image quality in segments 
of the left liver lobe (adjacent to the heart) and in cranial segments, while image quality in caudal left segment V 
and VI showed the best image quality. Electrocardiography gating might improve image quality, which was not 
tested in this study.
Figure 1. T2* and T1 mapping in a reference patient (male, 73 years old). Parametric maps with T2* on the left 
and T1 on the right are presented, from cranial (top) to caudal slices (bottom). Note the lower T2* values (blue) 
in cranial segments VII, VIII and IVa compared to the middle and lower slice (red) showing segments VI, V, 
IVb and III.
5Scientific RepoRts |          (2019) 9:8106  | https://doi.org/10.1038/s41598-019-44377-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
There are very few published data on normal T1 values of the liver at 3T using the MOLLI technique. Katsube et 
al. presented a mean value of 836 ± 69 ms in 16 patients with normal liver function. The slightly lower values in our 
study (780 ± 83 ms in reference patients, 799 ± 59 ms in healthy volunteers) may be explained by a smaller popula-
tion in the study of Katsube et al., as well as the by the fact that Katsube et al. defined the normal population based 
on normal liver function in laboratory tests, which does not exclude patients with steatosis or early liver fibrosis23. 
Other published normal T1 values were generated with other mapping techniques, but are nevertheless in a similar 
range, such as 824 ± 61 ms in 26 healthy volunteers using a spiral GRAPPA-based method24, 825 ± 49 ms in 6 healthy 
Normal liver 
stiffness (shear 
modulus <2.8 
kPa) N p-value
Negative controls Positive controls
Healthy 
volunteers N p-value
Increased liver 
stiffness (shear 
modulus ≥2.8 
kPa) N p-value
Significantly 
increasing liver 
stiffness (shear 
modulus ≥3.5 kPa) N p-value
No Steatosis
T1 adjacent 
to the lung VII/VIII/IVa 746 ± 81 ms 78 764 ± 56 ms 12 0.291* 835 ± 106 ms 21 <0.001* 885 ± 98 ms 13 <0.001*
T1 not 
adjacent to 
the lung
VI/V/IVb/II/III 780 ± 83 ms 78 799 ± 59 ms 12 0.358* 849 ± 107 ms 23 0.011* 910 ± 98 ms 13 <0.001*
Steatosis
T1 adjacent 
to the lung VII/VIII/IVa 809 ± 100 ms 24 0.009* 843 ± 141 ms 15 0.544** 906 ± 46 ms 6 0.013**
T1 not 
adjacent to 
the lung
VI/V/IVb/II/III 833 ± 95 ms 24 0.019* 889 ± 148 ms 14 0.269** 932 ± 41 ms 6 0.013**
Table 4. T1 values of lung-adjacent and non-lung-adjacent liver segments in all study participants (patients 
n = 143, volunteers n = 12, total n = 155). Values represent the mean ± SD or n. P-values were calculated using 
the Mann-Whitney U test, *compared to patients with normal liver stiffness without steatosis, **compared to 
patients with normal liver stiffness with steatosis.
Figure 2. T1 values of liver segments adjacent to the lung and liver segments not adjacent to the lung in 
different patient groups. T1 values are illustrated as mean and standard deviation in ms for liver segments 
adjacent to the lung in blue and for liver segments not adjacent to the lung in red. Panel (A) compares 
all participants without liver steatosis: reference population (normal liver stiffness, no steatosis), healthy 
volunteers, increased liver stiffness (LS) ≥ 2.8 kPa and ≥3.5 kPa. In panel (B) T1 values of the reference 
population are compared with patients with liver steatosis and normal LS (<2.8 kPa) and increased LS (≥2.8 
and ≥3.5 kPa). P-values were calculated using the Mann-Whitney U test. LS = liver stiffness.
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volunteers using an inversion recovery method with refocusing pulses25, and 745 ± 65 ms in 8 healthy volunteers 
using MR fingerprinting26. Slight differences might be explained by different techniques of assessment and small 
sample sizes used in the cited studies. This underlines the recommendation, that normative values should be estab-
lished for the particular site and set-up for different manufacturers, technical parameters and field strengths before 
using T1 mapping in clinical routine15,16. In accordance with other published studies, increased T1 time correlated 
with increased liver stiffness in MR elastography as a non-invasive surrogate for liver fibrosis2,13,14,23. Yoon et al. pub-
lished T1 values in patients with chronic liver disease (863 ± 81 ms) and Child A liver cirrhosis (879 ± 86 ms)27 in the 
same range as we present here (849 ± 107 ms for early liver fibrosis and 910 ± 98 ms for significant fibrosis). T1 values 
calculated with commercially available software solutions using the MOLLI mapping technique have been shown to 
correlate with the severity of NAFLD/NASH and fibrosis28 and may predict clinical outcome in these patients29. We 
demonstrated an increased T1 time in patients with steatosis, which is in accordance with other published studies30. 
This is a paradox, since fat has a much shorter T1 time than water. According to recent publications, off-resonance 
effects in imaging voxels containing a mixture of fat and water signals may explain this finding31,32.
In addition to fat and fibrosis content as well as susceptibility-effects in liver segments adjacent to the lung, there 
are several other potential confounders of T1 and T2*. One known confounder inducing T1 shortening is liver iron 
content2,33, however patients with iron overload have been excluded in this study. Liver blood distribution and oxy-
genation levels are might influence T1 and T2* times as well. These effects and possible influences on T1 and T2* need 
further investigation. In multivariate analysis of reference patients without focal or diffuse liver disease and healthy 
volunteers, we could not demonstrate a significant age- or sex- dependency of the measured T1 values. However, 
there was a collinearity between T1 and T2* values. Further research should be performed to show whether T1 is 
T2* dependent (e.g. due to fat, iron composition, blood distribution and eventually blood oxygenation influencing 
T2*) or whether it is the other way round and T2* is influenced by T1 due to a too short TR in the used T2*-mapping 
sequence. Also using a multiparametric approach combining T1, T2*, MRE and PDFF might deliver further insights.
Our study highlights the importance of standardized technical parameters and well-defined normal values 
when performing T1 mapping of the liver. For an accurate non-invasive characterization of diffuse liver disease, a 
combined analysis of different MR parameters such as T1 mapping, T2* mapping, elastography and PDFF should 
be performed. Further research will show how a multiparametric combination of those MR imaging biomarkers 
may help differentiating and quantifying diffuse liver disease.
Limitations. Our study has several limitations. First, we focused on a population without known chronic liver 
disease. Due to the study design and associated ethical considerations, liver biopsy was not possible. Instead, we 
used MR elastography and PDFF, which have been shown to correlate very well with biopsy-confirmed fibrosis34 
and steatosis grades35, as the non-invasive gold standard, and we included negative and positive controls based 
on these imaging techniques. Another limitation is that we did not obtain full 3D coverage of the liver, as we used 
commercially available Siemens MOLLI sequences with 2D acquisitions on three transverse slices. Nevertheless, 
we present a segmental comparison of T1 mapping in a reference population, as well as in negative and positive 
controls. Newer 3D mapping sequences or MR fingerprinting may offer even more applications for future use.
Conclusion
When analysing T1 maps in the liver at 3T, we propose to measure T1 relaxation times in liver segments not 
adjacent to the lung. Otherwise, we recommend taking into account slightly shorter T1 normal values in liver 
segments adjacent to the lung.
Figure 3. Correlation among MR elastography and T1 and T2* values. Subgroups are color-encoded for better 
illustration. Measured liver stiffness without steatosis is demonstrated in green if <2.8 kPa and in blue if ≥2.8 
kPa Patients with steatosis are shown in yellow (10–20% fat) and red (>20%), respectively. (A) Comparison 
of T2* and MR elastography without significant correlation in any group. (B) Comparison of T1 with MR 
elastography.
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Methods
study population. This prospective cross-sectional study was approved by the institutional review board 
(Kantonale Ethikkomission Bern, IRB number 282–15) and was conducted in accordance with relevant guide-
lines and regulations after obtaining written patient informed consent. All participants underwent multiparamet-
ric MR imaging at 3T in our institution between 03/2016–06/2017, including T1 and T2* mapping, proton density 
fat fraction (PDFF) quantification and MR elastography.
A total of 161 study participants were recruited, while 6 patients had to be excluded due an incomplete MR 
exam due to claustrophobia or technically uninterpretable MR elastography. Resulting study population consisted 
of twelve healthy volunteers without a history of liver disease (negative controls) and 143 patients (Fig. 5). The 
included 143 patients were selected based on acquired abdominal computed tomography (CT) scans without 
focal liver disease (cysts > 2 cm, solid lesion >1, prior liver surgery). Out of the 143 patients, we then defined 
a reference population (n = 79) without focal (based on CT) or diffuse liver disease (based on MR elastography 
shear modulus < 2.8 kPa and PDFF < 10%). CT scans in the reference population were performed with following 
indications: trauma (n = 14), abdominal pain (n = 19), infection (n = 23) and tumor search (n = 23). The remain-
ing patients (n = 64) were assigned to positive control groups with diffuse liver disease (MR elastography shear 
modulus ≥2.8 kPa and/or PDFF ≥10%).
Clinical information and laboratory test results were recorded for the included patients. Clinical parameters 
included age, gender, body mass index (BMI), history of diabetes or hypertension, daily drug intake, tobacco use 
and alcohol consumption. Biological parameters included dyslipidemia, platelet count, quick value, total biliru-
bin levels, gamma-glutamyltranspeptidase (GGT), aspartateaminotransferase (AST), alanine aminotransferase 
(ALT), alkaline phosphatase, albumin, creatinine and hematocrit.
sample size estimation. To detect a mean difference in T1 of 5% (=40 ms) between the upper and lower 
liver segments with a significance level of 0.05 and a power of 0.8, a sample size of 72 was needed. A mean T1 time 
of 800 ms with standard deviation of 85 ms was based on a pilot readout for sample size calculations.
MR imaging technique. Patients were examined with a 3T-MR system (Verio, Siemens Healthineers) in a 
fasting state (>6 h). For T1 mapping, we used an axial-acquired, MOLLI single breath-hold sequence (echo time 
(TE) of 1.01 ms, data acquisition window of 740 ms, inversion time (TI) 225 ms (3 inversion pulses, starting at 
65 ms with an increment of 80 ms), flip angle (FA) 35°, 8-mm slice thickness, field-of-view (FOV) 384, matrix 
154 × 192 pixels, and scan time of 11 s) with a 3-3-5 design (acquisition during 3 heartbeats, pause during 3 
heartbeats for relaxation purposes and acquisition during another 5 heartbeats). T2* mapping was performed 
Figure 4. Localization of acquired maps. Correlation of T2* maps (B,E), T1 maps (C,F) and coronal T2w 
HASTE images (A,D) for two patients are shown. The yellow box in displays A and D indicate the location of 
the 10 mm thick mapping slices. The green lines show the area with lower relaxation times and their distance 
from the liver border. The red lines demonstrate the distance from there to the liver dome. In the patient in the 
upper row (A–C), a 67-year-old man, partial volume is a good explanation for shorter relaxation times with 
obvious artefacts in Segment VII on the T1map (C), while in the other patient (D–F), a 30-year-old women, 
shorter relaxation times cannot be explained by partial volume alone. Although patient might have shown 
different breathing between coronal and axial sequences, no significant difference in acquisition level is to 
assume since the stomach is still seen on axial slices.
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with a multiecho gradient echo (GRE) single breath-hold sequence (12 echoes with a TE between 0.93–14.2 ms, 
TR of 200 ms, FA 18°, FOV 400, 10-mm slice thickness, and scan time of 19 s). T1 and T2* maps were generated 
on three single slices in the upper, mid and lower liver. PDFF was calculated using the Dixon method with axial 
T1-weighted axial vibe images (TE of 2.45 ms and 3.68 ms, TR of 5.47 ms, FA 9°, 3-mm slice thickness, and scan 
time of 22 s) to differentiate patients with and without liver steatosis. For MR elastography, a pneumatic driver 
(Resoundant) was placed on the right upper quadrant transmitting shear waves by continuous acoustic vibrations 
with a frequency of 60 Hz. The liver shear stiffness in kPa in the right upper liver lobe was determined with a 
gradient echo-based elastography sequence (WIP package 622 provided by Siemens Healthineers, 3 single-slice 
acquisitions with 5-mm slice thicknesses) using the 95% confidence map of stiffness. A shear modulus ≥2.8 kPa 
was considered to represent early liver fibrosis (corresponding to histology fibrosis grade ≥F1, according to the 
Metavir staging system), while a shear modulus ≥3.5 kPa was defined as significant liver fibrosis (corresponding 
to histology fibrosis grade ≥F3)8,36,37.
MR imaging analysis. Prior to any measurements image quality on relaxometry maps was assessed by an 
experienced radiologist (V.O., 5 years of experience in hepatic imaging). For T1 and T2* mapping, 8 polygonal 
regions of interest (ROI) were drawn in liver segments II-VIII by the radiologist (V.O.) who was blinded to the 
patient’s clinical history. In liver segments without excellent image quality (e.g. due to motion artefacts) or in 
segments that were not captured on any of the three acquired slices, no ROI was drawn at this location, and thus 
no value was assigned to the respective segment. The mean ROI size was 685 ± 203 mm2. Large blood vessels, bile 
ducts and regions with partial volume, including air or perihepatic fat at the liver border, were excluded (Fig. 6). 
Another radiologist (A.H.), who was blinded to the patient’s clinical history and had 7 years of experience in 
hepatic imaging, measured the shear modulus (in kPa) on MR elastography images and the PDFF (in %) based on 
in- and out-of-phase DIXON images in the right liver on three slices, using polygonal ROIs to exclude vessels and 
partial volume at the liver borders. The median value of the three ROIs was then calculated.
statistical analysis. Analysis was performed with the statistical software package R (version 3.4.1, R 
Foundation for Statistical Computing)38 and GraphPad Prism (version 7.1, GraphPad Software Inc.). Clinical 
characteristics were compared between groups using the Wilcoxon test for continuous variables or Fisher’s exact 
test for categorical variables. The p-value for significance was <0.05. T1 and T2* mapping parameters with good 
quality were then compared between segments using a paired Wilcoxon test. To address intersegmental variabil-
ity and to identify the best area for reference, the median values of the liver segments adjacent to the lung (VII, 
VIII, IVa) and those not adjacent to the lung (VI, V, IVb, II, III) were calculated for the reference population and 
compared with the negative and positive controls using the Wilcoxon test.
To assess possible confounders in the reference population and among healthy volunteers (n = 79 + 12), a 
multivariate regression model was used with T1 (segments not adjacent to the lung) as the outcome and sex 
(dummy-coded), age, PDFF and T2* (segments not adjacent to the lung) as variables. Age and sex were chosen as 
basic demographic characteristics that might bias the measured T1 in the liver while PDFF and T2* were added 
as known representatives of liver fat and iron content that might influence T1. Pearson correlation was used to 
Figure 5. Study participant workflow. A total of 161 participants were recruited for the study. Six patients were 
excluded because of an aborted MRI scan due to claustrophobia (n = 1) or due to technically inadequate MRE 
scans (n = 5). Resulting included study population consisted of 12 healthy volunteers with normal liver stiffness 
and without steatosis (negative controls) and 143 patients without focal liver disease on CT. The MRI scans of 
143 patients were included in statistical analysis. There were 102 patients who did not show steatosis, and 79 of 
these 102 patients also showed normal liver stiffness (reference patients). The remaining 23 showed increased 
liver stiffness (≥2.8 kPa). Forty-one patients had liver steatosis with PDFF > 10% (26 with normal liver stiffness, 
15 with increased liver stiffness). Patients with increased liver stiffness and/or steatosis were defined as positive 
controls.
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compare MR elastography shear modulus with T1 values. For interrater reliability, T1 and T2* relaxation time was 
measured in segment VI in 20 randomly selected consecutive patients by a second radiologist (A.H.), who was 
blinded to the patient’s clinical history and had 7 years of experience in hepatic imaging. The two-way consistency 
intraclass correlation (ICC) was then calculated and classified as follows: ICC 0.4-0.59 defined as fair; 0.6–0.74 
defined as good; and 0.75–1.00 defined as excellent39.
Human subject research. This prospective cross-sectional study was approved by the institutional review 
board (IRB number 282-15) and was conducted after obtaining written patient informed consent.
Data Availability
Data generated for analysis during this study are included in this published article. Original patient data files 
are precluded from dissemination following Swiss Federal Law regulations (https://www.admin.ch/opc/de/of-
ficialcompilation/2013/3381.pdf). Data requests may be sent to: Kantonale Ethikkommission für die Forschung 
Murtenstrasse 31, 3010 Bern (Tel. +41 31 633 70 70, Fax +41 31 633 70 71, info.kek.kapa@gef.be.ch).
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